What Vipragen Biosciences does
Founded in 2012, Vipragen Biosciences operates in Health Tech industry. Initially focused on providing toxicology and pharmacology studies, the company has since broadened its services to include pharmacokinetics and molecular biology. The firm has been expanding its infrastructure and capabilities, exemplified by receiving investments to enhance facilities and services. Vipragen Biosciences has also ventured into advanced research segments such as drug discovery and screening. Competing with companies such as Pandorum Technologies and String Bio.
Who runs it
Funding and finances
Why this matters to you: funding stage is a rough proxy for how long the runway is and how much structure to expect. It is not a promise, and a profitable bootstrapped company can be the safer bet.
Check the company’s own careers page — linked at the top — before a job board. A role appears there first, sometimes weeks before it is syndicated anywhere else.
Questions and experiences
Nobody has asked anything about Vipragen Biosciences yet. If you have interviewed here, what you know is worth more to the next person than anything on the rest of this page.
Company facts compiled from public sources and last refreshed 9 September 2026. Details change; treat the company’s own site as the authority.